Pure Global
NCT04930484

Validity and Reliability of the Turkish Version of Performance Measure for Activities of Daily Living-8

Cultural Adaptation, Validity and Reliability of the Turkish Version of Performance Measure for Activities of Daily Living-8
Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital·ClinicalTrials.govCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Congestive Heart Failure
Study type
Observational
Sponsor & location
Primary sponsor
Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital
Location
Akçaabat,Trabzon, Turkey
Timeline & enrollment
Phase
N/A
Start date
Feb 03, 2021
End date
Aug 03, 2021
Enrollment
68 participants
Primary outcome

Performance Measure For Activities Of Daily Living-8,Chronic Heart Failure Questionnaire,Nothingham Health Profile,Sociodemographic data form

Summary

Chronic heart failure (CHF) is characterized by limited exercise performance, which is mainly
 determined by disease-specific factors, such as diminished cardiac output, abnormal
 ventilatory response, and low perfusion in skeletal muscles, which lead to skeletal muscle
 dysfunction.1 Exercise intolerance and symptoms may lead to activity restriction and further
 functional deterioration with the progression of CHF. There is some evidence that
 disease-specific self-report measures more quantify clinically relevant domains than measures
 of general health status and are generally more sensitive to clinical change. aim of the
 study is to investigate the validity and reliability of the PMADL-8 questionnaire in the
 Turkish population.

ICD-10 classifications
Congestive heart failureHeart failureHypertensive heart disease with (congestive) heart failureHypertensive heart and renal disease with (congestive) heart failureHeart failure, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04930484
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04930484 through Pure Global AI's free database. This phase not specified trial is sponsored by Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital and is currently Completed. The study focuses on Congestive Heart Failure. Target enrollment is 68 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.